FDA Inspection 1043191 — Millipore (U.K.) Ltd.

Millipore (U.K.) Ltd. — FEI 3002638287

The FDA completed an inspection of Millipore (U.K.) Ltd. on February 26, 2018 in Livingston. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 26, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Livingston (United Kingdom)